T. Spitznagel
Papers
2
Total Citations
59
H-Index
2
About
T. Spitznagel is a leading urologic surgeon and researcher specializing in focal therapy for prostate cancer, with a particular focus on high-intensity focused ultrasound (HIFU) and salvage surgical techniques. Their landmark 2019 prospective multicentre study on HIFU for focal prostate cancer treatment, cited 42 times, established crucial safety benchmarks and complication profiles that have guided clinical adoption of this minimally invasive approach. Spitznagel’s most impactful contribution addresses the critical challenge of treatment failure, as demonstrated in their 2021 study comparing salvage robotic-assisted laparoscopic radical prostatectomy (S-RALP) after HIFU to primary RALP. This work, with 17 citations, provides essential evidence that salvage surgery remains feasible and safe following focal therapy, offering patients a second chance at curative treatment. By systematically evaluating outcomes across two centers, Spitznagel has helped define the therapeutic pathway for men who experience recurrence after HIFU, bridging the gap between focal and radical treatments. Their research directly informs clinical decision-making for urologists managing complex prostate cancer cases, and their work continues to shape the evolution of organ-sparing oncologic surgery.
Research Focus
Key Achievements
Top Papers
- 1
- 2